secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2026-06-12T20:19:09+00:00
Accession:  0001193125-26-269493
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Whitehawk Therapeutics shareholders elect three Class III directors at annual meeting
--------------------------------------------------------------------------------

- Behzad Aghazadeh, Richard Maroun, and Emma Reeve elected as Class III directors with 26.7M, 27.7M, and 27.7M votes for, respectively.
- Advisory say-on-pay passed with 22.9M for, 6.0M against, 3.6M abstain.
- Ratification of BDO USA as auditor for FY 2026 passed with 34.8M for, 1.1M against, 4.4M abstain.
- Approximately 82% of voting power (40.4M shares) present, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/whwk-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer